Quantcast

Latest Amortization Stories

2014-10-30 08:41:31

- Revenues up 41% year-over-year to $14.1M MOUNTAIN VIEW, Calif., Oct. 30, 2014 /PRNewswire/ -- CEVA, Inc. (NASDAQ: CEVA), the leading licensor of DSP-based IP platforms for vision, audio, communications and connectivity, today announced its financial results for the third quarter ended September 30, 2014. http://photos.prnewswire.com/prnvar/20141030/155417-INFO Total revenue for the third quarter of 2014 was $14.1 million, an increase of 41% compared to $10.0 million for the third quarter of...

2014-10-30 08:41:16

NEW YORK, Oct. 30, 2014 /PRNewswire/ -- -- Revenues increased 29% year-over-year to $67.6 million in the third quarter -- Net income totaled $9.5 million, resulting in earnings per diluted share of $0.18, reflecting the impact of recognition of tax loss carryforwards of $1.7 million or $0.03 per diluted share -- Cash flows from operations totaled $14.3 million during the third quarter, up $8.2 million or 135% from the prior year quarter --...

2014-10-30 08:39:00

US $ -- Q3 adjusted EBITDA of $112 million / net income of $0.18 per share, excluding special items -- Strong performances once again for wood products and pulp -- Thunder Bay pellet plant ramping up; Ignace sawmill about to start -- Closure costs and impairment contribute to GAAP net loss of $116 million / $1.23 per share MONTREAL, Oct. 30, 2014 /PRNewswire/ - Resolute Forest Products Inc. (NYSE: RFP)...

2014-10-30 08:35:27

Company Records $3.7 million in Operating income on $33.5 million in revenue MARIETTA, Ga., Oct. 30, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its results for the third quarter ended September 30,...

2014-10-30 08:35:03

Company Raises Full-Year Revenue Guidance to $85.0 to $86.5 Million FT. MYERS, Fla., Oct. 30, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter of 2014. Third Quarter 2014 Highlights: -- 38% increase in consolidated revenue -- 23% growth in base NeoGenomics revenue -- 33% growth in base NeoGenomics test volume -- Consolidated Adjusted EBITDA increase of...

2014-10-30 08:34:56

- Solid third quarter results reported and strong fourth quarter expected - EAST RUTHERFORD, N.J., Oct. 30, 2014 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) reports results for the third quarter ended September 30, 2014. Highlights -- Third quarter sales increased 4.0% to $81.1 million from $78.0 million in the same period last year. -- Third quarter EBITDA increased 6.5% to $18.1 million compared to $17.0 million in the same period last year (see table at the...

2014-10-30 08:34:34

- Non-GAAP(1) operating earnings increased 6 percent to $566 million DUBLIN, Ohio, Oct. 30, 2014 /PRNewswire/ -- Cardinal Health today reported fiscal year 2015 first-quarter revenue of $24.1 billion and non-GAAP diluted earnings per share (EPS) from continuing operations of $1.00. Non-GAAP operating earnings increased 6 percent to $566 million. On a GAAP basis, operating earnings decreased 1 percent to $466 million, and diluted EPS from continuing operations decreased 21 percent to $0.78....

2014-10-30 08:34:25

- Record 675 HeartWare® Ventricular Assist Systems sold worldwide in Q3 FRAMINGHAM, Mass., Oct. 30, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $68.6 million for the third quarter ended September 30, 2014, a 25% increase compared to $54.8 million in revenue for the same period of 2013. During...

2014-10-30 08:34:11

SCHAUMBURG, IL, Oct. 30, 2014 /PRNewswire/ - Catamaran Corporation ("Catamaran" or the "Company") (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management ("PBM") services and technology, announces its financial results for the three and nine months ended September 30, 2014. Q3 2014 Highlights -- Revenue increased 53% to $5.5 billion in Q3 2014, compared to $3.6 billion in Q3 2013 -- Gross profit increased 22% to $351.5...

2014-10-30 08:33:59

$109.6 Million in 3Q 2014 Net Revenues Driven by Strong XIAFLEX Growth; Company Returns to Profitability with 3Q Non-GAAP EPS of $0.27 per Share CHESTERBROOK, Pa., Oct. 30, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for the third quarter ending September 30, 2014. The Company highlighted important corporate, commercial, regulatory and clinical development updates from the...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.